It is argued that heterogeneity, rather than mitochondrial biology itself, determines therapeutic tractability, and mitochondrial modulation is unlikely to provide a universal disease-modifying strategy, but remains a useful, carefully targeted addition for patient groups identified by genetic or specific biological ma...
M. Mamala, Izabela Skowron, K. Marczuk et al.· Cells· 0 citations
Variations in chemical composition, determined by geographical origin, and an insufficient number of rigorous clinical data hinder the full medical implementation of Pelargonium graveolens L’Hér.
Kamil Bukowiec, M. Sroka, Agata Pałkiewicz et al.· Applied Sciences· 0 citations
This review highlights the synergy between AI and HTS, emphasizing DL techniques such as convolutional neural networks for bioactivity prediction, recurrent neural networks for de novo design, and reinforcement learning for property optimization.
Kamil Herbetko, Katarzyna Herbetko, Magdalena Mikołajek et al.· Future Medicinal Chemistry· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
